BPC 157 has 500 plus preclinical publications. Fewer than 30 humans in published trials. Across 30 years of research. A Phase I trial enrolled 42 people in 2015 and never published its results. Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia reperfusion injury following Pringle maneuver, and Budd Chiari syndrome The influence of a novel pentadecapeptide, BPC 157, on NG nitro l arginine methylester and l arginine effects on stomach mucosa integrity and blood pressure ScienceDirect Peptide Therapy for Pain Management and Healing Core Medical & Wellness
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
bpc-157 randomized controlled trial human The Peptide Plastic Surgeon: A Review of Evidence on Regenerative Peptide Supplementation and Potential in Aesthetic Plastic Sur